107 related articles for article (PubMed ID: 36604220)
1. Rad Chat letter to the editor.
McNamara J; Julka-Anderson N
Radiography (Lond); 2023 May; 29 Suppl 1():S138-S139. PubMed ID: 36604220
[No Abstract] [Full Text] [Related]
2.
Koh SJQ; Sim DKL; Neo SH
J Palliat Med; 2023 Jul; 26(7):893-895. PubMed ID: 37428968
[No Abstract] [Full Text] [Related]
3. An article on "letter to the editor".
Pandarathodiyil AK; Vijayan SP; Sivapathasundharam B
J Oral Maxillofac Pathol; 2023; 27(2):254-256. PubMed ID: 37854909
[TBL] [Abstract][Full Text] [Related]
4. Letter to the Editor: ChatGPT's contribution to cancer study.
Faraji N; Aali S; Motiei M; Sadat Mansouri S
J Cancer Res Clin Oncol; 2023 Nov; 149(14):13495-13500. PubMed ID: 37462773
[TBL] [Abstract][Full Text] [Related]
5. Authors' response to letter to the editor, letter to the editor: Authors' response to letter to the editor: Safety concerns with human papilloma virus immunization in Japan: Analysis and evaluation of Nagoya City's surveillance data for adverse events.
Yaju Y; Tsubaki H
Jpn J Nurs Sci; 2020 Jan; 17(1):e12310. PubMed ID: 31788952
[No Abstract] [Full Text] [Related]
6. How to write an editorial letter?
Süer E; Yaman Ö
Turk J Urol; 2013 Sep; 39(Suppl 1):41-3. PubMed ID: 26328135
[TBL] [Abstract][Full Text] [Related]
7. Letter to the Editor - The implications of the professionalization of health promotion in Canada: a response to JR Graham's letter to the editor.
Gagné T; Lapalme J; Leroux J
Health Promot Chronic Dis Prev Can; 2017 May; 37(5):172-173. PubMed ID: 28493661
[TBL] [Abstract][Full Text] [Related]
8. Letter #1 Response to letter to Editor by Dr. Sarkar et al. for' who said differentiating preeclampsia from COVID-19 infection was easy? Refers to PII: S2210-7789(21)00539-0 Letter #2 Response to letter to Editor by Dr. Hantoushzadeh et al. for' is COVID-19 disease a risk factor for preeclampsia? Should aspirin be considered for prophylaxis of preeclampsia in these patients?' Refers to PII: S2210-7789(21)00538-9.
Jayaram A; Buhimschi IA; Buhimschi CS
Pregnancy Hypertens; 2022 Mar; 27():94-95. PubMed ID: 34973599
[No Abstract] [Full Text] [Related]
9. Letter to the Editor Regarding "Editor-in-Chief's April 2021 Letter on 'The Humility Button'".
Shlobin NA
World Neurosurg; 2022 May; 161():209-210. PubMed ID: 35505528
[No Abstract] [Full Text] [Related]
10. Reply to Letter to the Editor: Author Response to Letter to the Editor.
Granger CJ; Aiyer AA; McCormick KL; Levine WN
J Am Acad Orthop Surg; 2023 Feb; 31(3):e133-e134. PubMed ID: 34534168
[No Abstract] [Full Text] [Related]
11. Letter to the Editor Re: Author's Response to Letter to the Editor.
Ikeda T; Tsuboya T
Arch Phys Med Rehabil; 2020 Jun; 101(6):1096-1097. PubMed ID: 32156421
[No Abstract] [Full Text] [Related]
12. Role and importance of journal reader: Scientific contribution of letter to editor.
Kumar R
J Family Med Prim Care; 2022 Aug; 11(8):4117-4118. PubMed ID: 36352936
[TBL] [Abstract][Full Text] [Related]
13. Response Letter to the Editor in Reference to Letter to the Editor about "Does Overall Catastrophic Health Care Expenditure Make Sense"?
Etemadi M; Aryankhesal A
Iran J Public Health; 2018 Aug; 47(8):1230-1231. PubMed ID: 30186805
[No Abstract] [Full Text] [Related]
14. How to write a letter to the editor: an author's guide.
Johnson C; Green B
J Chiropr Med; 2006; 5(4):144-7. PubMed ID: 19674686
[TBL] [Abstract][Full Text] [Related]
15. Letter to the Editor Regarding Editor-in-Chief's August 2021 Letter on "Leadership".
Shlobin NA
World Neurosurg; 2021 Nov; 155():205. PubMed ID: 34724740
[No Abstract] [Full Text] [Related]
16. Response Letter to the Editor in Reference to Letter to the Editor about "Molecular Characterization of Animal
Bozorgomid A; Nazari N; Beigom Kia E; Hajjaran H; Mohebali M; Aryaeipour M; Heidarian P; Ezati MS; Rokni MB
Iran J Public Health; 2018 Aug; 47(8):1210. PubMed ID: 30186795
[No Abstract] [Full Text] [Related]
17. Reply to Valeria Panebianco, Francesco Del Giudice, Yoshifumi Narumi, Giuseppe Simone, Ettore De Berardinis, and James Catto's Letter to the Editor re: Helena Vila-Reyes, G. Joel De Castro, and James M. McKiernan's Letter to the Editor re: Yunjin Bai, Yubo Yang, and Yin Tang's Letter to the Editor re: Andrea Necchi, Marco Bandini, Giuseppina Calareso, et al. Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study. Eur Urol 2020; 77:636-43. Eur Urol 2020;77:e158: Can mpMRI Replace Conventional Transurethral Resection of Bladder Cancer? Eur Urol 2021;79:e35-e36.
Vila-Reyes H; Joel DeCastro G; McKiernan JM
Eur Urol; 2021 Feb; 79(2):e54-e55. PubMed ID: 33248798
[No Abstract] [Full Text] [Related]
18. Reply to letter to the editor by Riquelme LF et al. entitled 'IDDSI letter to the editor'.
Rothenberg E; Bischoff SC; Thibault R
Clin Nutr; 2022 May; 41(5):1142-1143. PubMed ID: 35393142
[No Abstract] [Full Text] [Related]
19. Letter to the Editor Regarding: Editor-in-Chief Letter "Optimism versus Pessimism: The Choice Is Yours".
Fatima N
World Neurosurg; 2021 Apr; 148():234. PubMed ID: 33770841
[No Abstract] [Full Text] [Related]
20. RESPONSE TO LETTER TO THE EDITOR: "EFFECT OF INTRATYMPANIC DEXAMETHASONE ON BELL'S PALSY: LETTER TO THE EDITOR".
Inagaki A; Minakata T; Katsumi S; Murakami S
Otol Neurotol; 2021 Mar; 42(3):483-484. PubMed ID: 33306664
[No Abstract] [Full Text] [Related]
[Next] [New Search]
